Sever Pharma Solutions AB

Poland

All drugs from this manufacturer

  • ASAMAX 250

    The medicine is used in the treatment of ulcerative colitis (mild to moderate) and Crohn's disease involving the colon. It helps to inhibit the progression of the disease process in the intestines during both the acute phase and the remission phase.

    Dosage form: tablets, enteric-coated

    Active substance Dosage
    mesalazine 250 mg

    ATC: A07EC02

  • ASAMAX 500

    The medicine is used for the treatment of ulcerative colitis (mild to moderate, in both acute phase and remission) and Crohn's disease involving the colon (also in acute phase and remission).

    Dosage form: tablets, enteric-coated

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02